The 22-year-old FDA warning advised doctors that hormone therapy increases the risk of blood clots, heart problems, and other ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

Interim data from the IQIRVO ® (elafibranor) ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers and consistent trends in ...

Diseases that primarily affect populations in low- and middle-income countries (LMICs) have a substantial toll on human health. Annually, more than one billion people are affected by a World Health ...